UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000011431 |
|---|---|
| Receipt number | R000013361 |
| Scientific Title | A feasibility Study Using Short-Term Cultured Anti-Tumor Autologous Lymphocytes Following a Lymphocyte Depleting Regimen in Metastatic Melanoma. |
| Date of disclosure of the study information | 2013/08/15 |
| Last modified on | 2019/01/26 18:10:15 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2013/08/08 21:31:27 | ||
| 2 | Update | 2013/09/03 21:48:24 | Email |
|
| 3 | Update | 2013/09/03 21:48:51 | Anticipated trial start date |
|
| 4 | Update | 2014/03/06 18:36:25 | Narrative objectives1 |
|
| 5 | Update | 2014/03/06 18:38:50 | Interventions/Control_1 Interventions/Control_1 |
|
| 6 | Update | 2014/03/06 18:39:42 | Anticipated trial start date |
|
| 7 | Update | 2014/08/08 18:19:12 | Anticipated trial start date |
|
| 8 | Update | 2014/10/08 19:46:01 | Recruitment status Anticipated trial start date |
|
| 9 | Update | 2014/11/14 19:40:30 | Recruitment status |
|
| 10 | Update | 2015/08/10 20:12:15 | Public title Public title Acronym Acronym |
|
| 11 | Update | 2015/08/10 20:13:05 | Primary outcomes Primary outcomes Key secondary outcomes Key secondary outcomes |
|
| 12 | Update | 2015/08/10 20:13:59 | Organization Organization Category of Funding Organization |
|
| 13 | Update | 2016/01/19 20:37:15 | Organization1 Tel1 Email1 |
|
| 14 | Update | 2016/01/19 20:38:03 | Date of protocol fixation Anticipated trial start date |
|
| 15 | Update | 2017/01/28 17:29:54 | Name of primary person or sponsor Organization Category of Funding Organization |
|
| 16 | Update | 2017/01/28 17:34:25 | Key inclusion criteria Key exclusion criteria |
|
| 17 | Update | 2018/02/07 20:43:05 | Recruitment status Last follow-up date |
|
| 18 | Update | 2019/01/26 18:10:15 | Recruitment status |
